Article Details

Gilead Shares Updated Data From Remdesivir Study In Pediatric COVID-19 Patients - Benzinga

Retrieved on: 2022-02-14 20:21:41

Tags for this article:

Click the tags to see associated articles and topics

Gilead Shares Updated Data From Remdesivir Study In Pediatric COVID-19 Patients - Benzinga. View article details on HISWAI: https://www.benzinga.com/general/biotech/22/02/25595856/gilead-shares-updated-data-from-remdesivir-study-in-pediatric-covid-19-patients

Excerpt

Gilead Sciences Inc (NASDAQ: GILD) announced new data from an interim analysis of its ongoing, Phase 2/3 study of Veklury (remdesivir) in ...

Article found on: www.benzinga.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up